EP300 and myelodysplastic syndrome: CBP/p300 activators. Despite the rarity of the t(2;11)(q31;p15) in MDS, NUP98-HOXD13-driven MDS mice have been studied since 2005 because they accurately reflect the clinical behavior of human MDS39,40.